How bout those Amylin hires!

Quote
Anonymous said:
Glad they are smart.....now if they just knew how to sell, we'd be in business. Unfortunately, they don't. 90% of Amylin's salesforce was taken from Novo's old salesforce 8 years ago. It was the people who "consulted" with their physicians....and never sold anything. Somehow we brought them back. Bad idea.....
Click to expand...

Never a more incorrect statement. I worked at Amylin since launch, and the idea that most reps were from Novo is flat out wrong. Actually, very few were. You'd think a lot would have been from Novo, but the truth is there were not. When you launch a 1st in class product, there will be a period of education. The Amylin reps did a great job at doing just that, and getting a lot of sales. The truth about Novo (if you have the honesty to admit it) is that you came in the picture two years later when all the "education" was done. You dolts came in and sold the QD vs BID advantage. It worked great, and in time you overtook Amylin sales...but not by much. When I left Amylin, I recall Amylin's total GLP sales (Bydureon and Byetta) creeping up and trending to retake share. Perhaps that's happened. Nonetheless, Amylin set the stage for Novo, and you dopes are too stupid, and unappreciative to admit it.
 




Anonymous said:
Never a more incorrect statement. I worked at Amylin since launch, and the idea that most reps were from Novo is flat out wrong. Actually, very few were. You'd think a lot would have been from Novo, but the truth is there were not. When you launch a 1st in class product, there will be a period of education. The Amylin reps did a great job at doing just that, and getting a lot of sales. The truth about Novo (if you have the honesty to admit it) is that you came in the picture two years later when all the "education" was done. You dolts came in and sold the QD vs BID advantage. It worked great, and in time you overtook Amylin sales...but not by much. When I left Amylin, I recall Amylin's total GLP sales (Bydureon and Byetta) creeping up and trending to retake share. Perhaps that's happened. Nonetheless, Amylin set the stage for Novo, and you dopes are too stupid, and unappreciative to admit it.
Click to expand...

The only truth to this statement is that Amylin was first. All the other stuff is mythical. Fact, and i worked in market research at IMS, doctors where pretty in the dark on GLP-1 and it's benefits. Amylin's top KOLs were aware but that was not the majority. Novo relaunched the class and expanded the marketplace as it should of with a better product with definitive advantages. Amylin was too small and didn't have the horsepower to drive market share as they should have before Novo came out with Victoza. At the end of the day its a classic example of not enough scale and scope to be successful. It had nothing to do with quality of rep interaction.
 




Anonymous said:
The only truth to this statement is that Amylin was first. All the other stuff is mythical. Fact, and i worked in market research at IMS, doctors where pretty in the dark on GLP-1 and it's benefits. Amylin's top KOLs were aware but that was not the majority. Novo relaunched the class and expanded the marketplace as it should of with a better product with definitive advantages. Amylin was too small and didn't have the horsepower to drive market share as they should have before Novo came out with Victoza. At the end of the day its a classic example of not enough scale and scope to be successful. It had nothing to do with quality of rep interaction.
Click to expand...
I've waited a long time for someone to give an honest assessment. I am sick and tired of the corporate-speak and the juvenile taunting of our competitors and their products. I wish we had more like you, whoever you are. 400-rep Amylin was led by a deposed SVP from Pfizer or Merck, and had their hands tied by Lilly's 1987 vintage strategy. Of course I am happy our stock is flying, but the flag waving of many of us here makes me sick. I can see why so many industries laugh when they see pharmaceutical company marketing or sales on a resume....
 




Anonymous said:
The only truth to this statement is that Amylin was first. All the other stuff is mythical. Fact, and i worked in market research at IMS, doctors where pretty in the dark on GLP-1 and it's benefits. Amylin's top KOLs were aware but that was not the majority. Novo relaunched the class and expanded the marketplace as it should of with a better product with definitive advantages. Amylin was too small and didn't have the horsepower to drive market share as they should have before Novo came out with Victoza. At the end of the day its a classic example of not enough scale and scope to be successful. It had nothing to do with quality of rep interaction.
Click to expand...

You're full of shit. You Novo dopes are so full of yourselves. Blow me.
 




Anonymous said:
You're full of shit. You Novo dopes are so full of yourselves. Blow me.
Click to expand...

Funny. If you would have been here at the Victoza launch, you would have realized that all the effort Amylin put into "educating" the physicians on GLP-1 only resulted in their using Byetta for weight loss. Nothing else. They knew nothing about the underlying GLP-1 deficiencies, and they had no idea how Byetta worked. In short, you did nothing to help the Victoza launch by "paving the way" for us. We had to clean up your mess and put the focus back on controlling diabetes rather than losing weight. Another example of Amylin's failures when they had the opportunity to do something great. Back to my original point....not sure why anyone would hire a rep from Amylin. All they've done is repeated fail over and over again.
 












Anonymous said:
Funny. If you would have been here at the Victoza launch, you would have realized that all the effort Amylin put into "educating" the physicians on GLP-1 only resulted in their using Byetta for weight loss. Nothing else. They knew nothing about the underlying GLP-1 deficiencies, and they had no idea how Byetta worked. In short, you did nothing to help the Victoza launch by "paving the way" for us. We had to clean up your mess and put the focus back on controlling diabetes rather than losing weight. Another example of Amylin's failures when they had the opportunity to do something great. Back to my original point....not sure why anyone would hire a rep from Amylin. All they've done is repeated fail over and over again.
Click to expand...

You're full of shit.
 








Top Bottom
Back
Quote